drugset / Trial / NCT01900704
Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4
RandomizedParallel-groupTriple-blindTreatment
Summary
To investigate the efficacy and safety of SER120 nasal spray formulations in patients with nocturia
Timeline
- Start
- 2013-08
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 750 ng | Intranasal |
| Subject | Desmopressin | Peptide | 1500 ng | Intranasal |